← Back to Clinical Trials
Recruiting NCT06721312

NCT06721312 Continuous Heart Rate Variability Monitoring in Doctors; Understanding Patterns of Stress and Recovery and Their Relationship With Self-reported Resilience, Burnout and Wellbeing.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06721312
Status Recruiting
Phase
Sponsor University of Aberdeen
Condition Burnout
Study Type OBSERVATIONAL
Enrollment 60 participants
Start Date 2024-12-09
Primary Completion 2025-10-31

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 60 participants in total. It began in 2024-12-09 with a primary completion date of 2025-10-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Burnout is an increasing concern in the medical professions. This study aims to utilise established, validated self-report measures combined with continuous heart rate variability measurements to better understand the stress and recovery patterns experienced by doctors that may contribute to burnout. This mixed methods study design will consist of an ecological momentary assessment phase where participants will complete commonly used and validated real-time subjective measures while concurrently wearing a heart rate variability monitor to provide an objective measure of stress. Following on from this, participants of interest will be invited to participate in semi structured interviews to further explore their experiences of stress and recovery.

Eligibility Criteria

Inclusion Criteria: * Working within NHS Grampian * Access to a smartphone Exclusion Criteria: * Cardiac arrhythmias/endocrine disease. * Prescription beta blockers, calcium channel blockers, ACE inhibitors, benzodiazepines, antidepressants and antianxiety medications. * Insufficient non-working time prior to study commencement.

Contact & Investigator

Central Contact

Leia M Kane, BSc (hons), MBChB, FRCEM

✉ leia.kane@abdn.ac.uk

📞 07903669881

Frequently Asked Questions

Who can join the NCT06721312 clinical trial?

This trial is open to participants of all sexes, studying Burnout. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06721312 currently recruiting?

Yes, NCT06721312 is actively recruiting participants. Contact the research team at leia.kane@abdn.ac.uk for enrollment information.

Where is the NCT06721312 trial being conducted?

This trial is being conducted at Aberdeen, United Kingdom.

Who is sponsoring the NCT06721312 clinical trial?

NCT06721312 is sponsored by University of Aberdeen. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology